Template:Congestive heart failure: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''Congestive heart failure Microchapters | '''Congestive heart failure Microchapters''' | ||
''' | |||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
Line 173: | Line 173: | ||
:: [[Congestive heart failure positive inotropics|Positive Inotropics]] | :: [[Congestive heart failure positive inotropics|Positive Inotropics]] | ||
:: [[Congestive heart failure anticoagulants|Anticoagulants]] | :: [[Congestive heart failure anticoagulants|Anticoagulants]] | ||
:: [[Congestive heart failure angiotensin receptor-neprilysin inhibitor|Angiotensin Receptor-Neprilysin Inhibitor]] | |||
:: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]] | :: [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]] | ||
:: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]] | :: [[Congestive heart failure other pharmacotherapies#Nutritional Supplements|Nutritional Supplements]] |
Revision as of 22:56, 30 August 2014
Congestive heart failure Microchapters |
Differentiating Congestive heart failure from other Diseases |
---|
Diagnosis |
Treatment |
Medical Therapy: |
Surgical Therapy: |
ACC/AHA Guideline Recommendations
|
Specific Groups: |
Congestive heart failure On the Web |
Risk calculators and risk factors for Congestive heart failure |